Clinical trials
Phase 1 Thrombosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Recruiting | 4 |
| Unknown status | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 13 |
| Jiangsu HengRui Medicine Co., Ltd. | 4 |
| Aronora, Inc. | 2 |
| Bayer | 2 |
| National Institutes of Health Clinical Center (CC) | 2 |
| Sirius Therapeutics Co., Ltd. | 2 |
| University of Michigan | 2 |
| AdvanceCor GmbH | 1 |
| Archemix Corp. | 1 |
| Band Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombosis | 57 |
| Venous Thrombosis | 4 |
| Hemorrhage | 3 |
| Inflammation | 3 |
| Myocardial Infarction | 3 |
| Neoplasms | 3 |
| Stroke | 3 |
| Atrial Fibrillation | 2 |
| Cardiovascular Diseases | 2 |
| Embolism | 2 |
Trials
Showing 76 to 57 of 57. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.